National Bank of Canada
RCEL icon

National Bank of Canada’s Avita Medical RCEL Stock Holding History

National Bank of Canada’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-58,900
Closed -$301K – 3091
2025
Q3 		$301K Buy
+58,900
New +$307K ﹤0.01% 1453

Other funds holding RCEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

National Bank of Canada's RCEL Position: Q4 2025 in Review

National Bank of Canada sold out of Avita Medical (RCEL) in Q4 2025, closing a stake of 58,900 shares — an estimated $301K sold.

National Bank of Canada first reported a position in RCEL in Q3 2025 and held it in 1 quarter. The position peaked at $301K in Q3 2025. 67 funds tracked by Wall St. Rank hold RCEL as of Q4 2025.

  • National Bank of Canada reported no remaining Avita Medical position as of Q4 2025 after selling out during the quarter.
  • National Bank of Canada sold 58,900 Avita Medical shares in Q4 2025, an estimated $301K.
  • National Bank of Canada first reported a position in Avita Medical in Q3 2025 and held it in 1 quarter.
  • National Bank of Canada's Avita Medical position peaked at $301K in Q3 2025.
  • 67 funds tracked by Wall St. Rank held Avita Medical as of Q4 2025.

Based on National Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.